Replidyne, Inc.
Louisville, CO, US· latest recorded location
Replidyne, Inc. is named on 12 US grants and 18 published applications in this corpus. Its most frequent classification is C12N (Microorganisms or enzymes).
- Granted patents
- 12
- Published applications
- 18
- Inventors
- 29
- Granted in 2026 so far
- 0
- Most recent grant
- 6 May 2014
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 1 | 1 |
| 2005 | 2 | 0 |
| 2006 | 4 | 3 |
| 2007 | 2 | 3 |
| 2008 | 2 | 7 |
| 2009 | 0 | 3 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
By publication year.
Technology areas
Share of 30 documents
- C12NMicroorganisms or enzymes15
- A61KMedicines and medical preparations14
- C07DHeterocyclic compounds14
- A61PTherapeutic uses of medicines13
- C07KPeptides6
- C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms6
- G01NInvestigating or analysing materials by determining their chemical or physical properties6
- Y02ATechnologies for adaptation to climate change5
- C07CAcyclic or carbocyclic compounds2
- C12YEnzymes1
Recent patents
- Antibacteriall heterocyclic ureas6 May 2014US 8,716,320 B2
- Methionyl tRNA synthetase polynucleotides22 Apr 2008US 7,361,476 B2
- tRNA synthetase26 Feb 2008US 7,335,499 B2
- metRS24 Dec 2007US 7,304,152 B2
- Compositions and methods for topical administration of 2-NH-heteroarylimidazoles22 May 2007US 7,220,757 B2
- Bacterial replication systems and methods4 Feb 2010US 2010/0028862 A1
- Methods and compounds for treatment of clostridium based infection25 Jun 2009US 2009/0163536 A1
- Methionyl tRNA Synthetase Polynucleotides9 Apr 2009US 2009/0092592 A1
- Transition metal catalyzed cross-coupling of 1-halo-1-haloalkene compounds26 Feb 2009US 2009/0054667 A1
- Substituted Phenylether-Thienopyridone Compounds With Antibacterial Activity18 Sep 2008US 2008/0227808 A1
Most cited
By later US patents
- Thermophilic polymerase III holoenzyme6US 6,677,146 B12004
- 2-NH-heteroarylimidazoles with antibacterial activity6US 6,943,175 B22005
- Substituted thiophenes with antibacterial activity4US 7,030,137 B22006
- Compositions and methods for topical administration of 2-NH-heteroarylimidazoles4US 7,220,757 B22007
- Antibacteriall heterocyclic ureas4US 8,716,320 B22014